×ðÁú¿­Ê±

English ×ðÁú¿­Ê±¼¯ÍÅÆóÒµÓÊÏä

B³¬²â¶¨×ðÁú¿­Ê±°ÌºÛÈí¸àÖÎÁÆÔöÉúÐÔñ£ºÛµÄÁÆÐ§ÆÊÎö£¨¸½470Àý±¨¸æ£©

2011Äê-07ÔÂ-08ÈÕ ÈªÔ´£ºÖйúÉÕÉË´´ÑñÔÓÖ¾Éç

ÁõÍò»Ô£¬ÁõÉÆÎ䣬Ëï±ò£¬ÖìÁá
×Ͳ©Êв©É½ÉÕÉËÕûÐÎÒ½Ôº£¬É½¶«¡¡×Ͳ©¡¡255200

      ¡¾ÕªÒª¡¿Ä¿µÄ£º±¾ÎÄÓ¦ÓÃB³¬Ì½²âÔöÉúÐÔñ£ºÛµÄºñ¶ÈºÍÔöÉúÐÔñ£ºÛÓëÖÜΧ×éÖ¯µÄÕ³Á¬¹ØÏµ£¬Äâ̽ÌÖÒ»Öֿ͹۵ġ¢ÎÞ´´µÄÁÆÐ§ÆÀ¼ÛÒªÁ죬Ïàʶ¶àÖÖÒªÁìÍŽáÖÎÁÆÔöÉúÐÔñ£ºÛµÄÁÆÐ§¡£ÒªÁ죺ѡÓÃÇкϱê×¼µÄ140Àý»¼Õß×÷ΪÊÓ²ì×飬²¢Ñ¡È¡20Àý´¿´âÓ¦ÓÃѹÁ¦ÁÆ·¨ºÍ30ÀýѹÁ¦ÁÆ·¨ÍŽá×ÌÈÅËØ¼¡Èâ×¢ÉäÖÎÁƵϼÕß×öΪ±ÈÕÕ×顣Ч¹û£º±¾×é140Àý»¼ÕßÖÐÏÔЧ120Àý¡¢ÓÐÓÃ20Àý¡¢ÎÞЧΪ0Àý£¬×ÜÓÐÓÃÂÊ100%¡£´¿´âÓ¦ÓÃѹÁ¦ÁÆ·¨ÒÔ¼°Ó¦ÓÃѹÁ¦+×ÌÈÅËØÁÆ·¨µÄ»¼Õߣ¬ÏÔЧºÍÓÐÓÃʱ¼ä±È×ðÁú¿­Ê±°ÌºÛÈí¸à+ѹÁ¦+×ÌÈÅËØÁÆ·¨Íí3¸öÔ¡£½áÂÛ£ºB³¬²â¶¨ÏÔʾȫ³ÌÓ¦ÓÃ×ðÁú¿­Ê±°ÌºÛÈí¸àºó£¬ñ£ºÛµÄºñ¶È¼°ÓëÖÜΧ×éÖ¯µÄÕ³Á¬¹ØÏµÓÐÏÔ×ŵĸÄÉÆ£¬²¢ÇÒ¸ÐÓ¦Ìñ¾²£¬ÊàŦ¹¦Ð§Ô˶¯¶ÈÏÔ×Å»ñµÃ¸ÄÉÆ¡£
      ¡¾Òªº¦´Ê¡¿ÔöÉúÐÔñ£ºÛ£»°ÌºÛÈí¸à£»B³¬¼ì²â£»Ñ¹Á¦ÁÆ·¨£»×ÌÈÅËØÁÆ·¨
      ¡¾±êʶ·û¡¿doi£º10.3969/j.issn.1001-0726.2010.03.021

      The Efficacy Obervation of MEBO Scar Lotion in Treating Hypertrophic Scar by Means of B-type Ultrasound Instrument for Scar Measurement £¨Attached 470 cases of Report£©.LIU Wan-hui£¬LIU Shan-wu£¬SUN Bin£¬et al.Boshan Burn and Plastic Hospital£¬Zibo City£¬Shandong province£¬255200£¬China.
      ¡¾Abstract¡¿ Objective£ºTo establish an objective and non-invasive method to estimate treating hypertrophic scar  and to understand the effect of combining multi-therapies in treating hypertrophic scar£¬B-type Ultrasound instrument was used for measurement of the scar thickness and for finding adhesion relationship of hypertrophic scars and its surrounding tissue.Method£º140 cases of hyperplastic scar matched the inclusion criteria were involved in treatment group.20 cases treated with simple pressure therapy and 30 cases treated with pressure plus interferon therapy were all collected as control group.Results£ºOf 140 patients in treatment group£¬120 cases were markedly effective£¬20 cases were effective and no one was ineffective.The total effective rate was 100%.The period of time to obtain the results of markedly effective and effective in the control group was 3 months later than that in treatment group which treated with MEBO Scar Lotion + pressure therapy + interferon therapy.Conclusion£ºThe results of Ultrasonic measurement showed that there was marked improvement observed in scar thickness and adhesions relations of scar with surrounding tissue.The patients satisfied with their comfort feeling and their significantly improved joint activity.
      ¡¾Key words¡¿ Hyperplasic scar£»MEBO Scar Lotion£»B type ultrasonic£»Pressure therapy£»Interferon

      ÔöÉúÐÔñ£ºÛ±¬·¢µÄÖ÷Òª»úÖÆÖ®Ò»ÊdzÉÏËάϸ°û²»¿É½øÈëÕý³£µÄ³ÌÐòÐÔéæÃü£¬µ¼ÖÂÆäÒì³£ÔöÖ³£¬Ê¹Ï¸°ûÍâ»ùÖÊÌ«¹ý³Á»ý¡£ÔÚÈËÌå´´ÉËÐÞ¸´µÄͬʱ»á±¬·¢ñ£ºÛ£¬µ«ñ£ºÛÐγɺóÌ«¹ýÉú³¤£¬¾Í»áÒý·¢Öݪֲ¢·¢Ö¢£¬ÈçÐÎ×´µÄÆÆËð¼°¹¦Ð§Ô˶¯Õϰ­µÈ¡£Òò´Ë£¬ÔöÉúÐÔñ£ºÛµÄ·ÀÖÎÊÇÉÕÉËÖÎÁƺóÆÚÒ»ÏîÖ÷ҪʹÃü¡£ÔöÉúÐÔñ£ºÛµÄÖÎÁÆ·ÖΪ·ÇÊÖÊõÖÎÁÆ£¬ÊÖÊõÖÎÁÆÒÔ¼°×ÛºÏÖÎÁÆ£¬ÆäÖзÇÊÖÊõÖÎÁÆ£¬ÎÞ´´¡¢ÎÞÍ´¿àÈÝÒ×±»´ó¶¼»¼Õß½ÓÊÜ¡£ÎÒ¿Æ×Ô2003ÄêÒÔÀ´£¬ÁÙ´²Ó¦ÓÃ×ðÁú¿­Ê±°ÌºÛÈí¸àÖÎÁÆÊý°ÙÀýñ£ºÛÔöÉú»¼Õߣ¬ÊÕµ½ÓÅÒìµÄЧ¹û¡£¼øÓÚ¶Ôñ£ºÛµÄ»ù´¡Ñо¿ÉÐÎÞÍ»ÆÆÐÔÏ£Íû£¬ÁÙ´²·ÀÖÎÉÐÎÞ³ÉÊì¼Æ»®£¬ÎÒ¿ÆÕë¶Ôñ£ºÛµÄÖÎÁƼƻ®ÊÇ£¬°ÑÔ¤·À²½·¥Ô¢ÓÚÖÎÁÆÖ®ÖУ¬·ÀÖÎÒ»ÌõÁú£¬Ö÷ÒªÒªµãÈçÏ£Û1£Ý£ºÒ»ÊÇÆð¾¢Ôö½ø´´ÃæµÄÔçÆÚÓúºÏ£»¶þÊÇÔÚ´´Ãæ»ù±¾ÓúºÏºóµÄ1Äê»ò2ÄêÄÚÆð¾¢½ÓÄÉÔ¤·ÀÖÎÁƲ½·¥£»ÈýÊÇ×¼Ê±Ëæ·Ã£¬¶¯Ì¬ÖÎÁÆ¡£ÆÀ¼ÛÔöÉúÐÔñ£ºÛÖÎÁƺͿØÖƵÄÒªÁìÖÖÀàÐí¶à£¬ÎÒ¿ÆÓ¦ÓÃB³¬Ì½²âÔöÉúÐÔñ£ºÛµÄºñ¶Èת±ä£¬ÊÇÒ»ÖÖ¾­¼Ã¡¢Àû±ã£¬Ð§¹û½ÏÁ¿¿É¿¿µÄÒªÁ졣ͨ¹ýB³¬Í¼Ïñ×ÊÁÏµÄ»Ò¶ÈÆÊÎöÒÔ¼°Ó¦ÓÃÊÓÆµÓ¡Ïó»ú¼Í¼ÓйØÍ¼Ïñ×ÊÁÏ£¬¿É¸øÁÙ´²Ò½ÉúÌṩÐÎ̬ѧ×ÊÁÏ£¬¿ÉÖ±½Ó¾ÙÐÐÁÙ´²ÆÀ¼Û¡£

1.ÁÙ´²×ÊÁÏ
      ×÷ÕßÔÚ2003Äê~2009Äê¼ä£¬ÁÙ´²ÍâÓÃ×ðÁú¿­Ê±°ÌºÛÈí¸àÖÎÁÆñ£ºÛ»¼Õß470Àý£¬ÆäÖÐÄÐ350Àý£¬Å®120Àý£¬Ñ¡ÆäÖÐÇкÏÊÓ²ì±ê×¼µÄ140Àý£¬×÷ΪÊӲ칤¾ß£¬²¢È¡20Àý´¿´âÓ¦ÓÃѹÁ¦ÁÆ·¨ÕߺÍ30ÀýѹÁ¦ÁÆ·¨ÍŽá×ÌÈÅËØ¼¡Èâ×¢ÉäÕß×÷Ϊ±ÈÕÕ×é¡£
1.1.²¡ÀýÑ¡Ôñ±ê×¼£º£¨1£©±¾×鲡Àý¾ùΪ´´ÃæÓúºÏºó×îÏÈÖÎÁÆ¡££¨2£©ÔöÉúÐÔñ£ºÛ²¿Î»ÒÔËÄÖ«Çû¸ÉΪÖ÷¡££¨3£©»¼ÕßÄܽÓÊÜÈ«³ÌÓ¦Óð̺ÛÈí¸àÖÎÁÆ£¬²¢ÇÒÄÜÑÏ¿áÆ¾Ìý˵Ã÷ÊéÓ¦Óᣣ¨4£©ÔöÉúÐÔñ£ºÛÃæ»ýÔÚ5%ÒÔÉÏ¡££¨5£©ÅäºÏѹÁ¦ÁÆ·¨»òÍŽá×ÌÈÅËØÈ«ÉíÖÎÁÆ¡££¨6£©Äܰ´ÆÚ¸´Õï¡£
1.2.ÁÆÐ§±ê×¼£ºÆ¾Ö¤ÁÙ´²Ö¢×´¸ÄÉÆµÄË®ÖзÖΪÏÔЧ¡¢ÓÐÓúÍÎÞЧÈýÀà¡£
      £¨1£©ÏÔЧ£ºÔöÉúÐÔñ£ºÛÍêÈ«³ÉÊ죬ÍÑÀëѹÁ¦ºó£¬ñ£ºÛ²»ÔÙ³äѪ£¬ÑÕÉ«ÓëÖÜΧÕý³£Æ¤·ô¿¿½ü£¬ñ£ºÛ±äƽ£¬ÈáÈí¶øÓе¯ÐÔ£¬Ñ÷Í´¸ÐÊÜÏûÊÅ¡£

      £¨2£©ÓÐÓãºÔöÉúÐÔñ£ºÛÉÐδµ½É±ÇàÊ죬ñ£ºÛ³äѪËäÒÑÏÔÖø¼õÇᣬµ«ÑÕÉ«»¹Î´×ªÎªÕý³££¬ñ£ºÛÂÔ¸ßÓÚÆ¤·ô£¬ÈáÈíµ«ÎÞµ¯ÐÔ£¬ÓÐÇá¶ÈÑ÷Í´¸ÐÊÜ¡£

      £¨3£©ÎÞЧ£ºñ£ºÛ֢״ˮƽÎÞÈκθıä¡£
1.3.ÒªÁ죺ÒÇÆ÷£º½ÓÄÉÈÕ±¾EUB-40Ðͼ°ÃÀ¹úSPECTRA²ÊÉ«¶àÆÕÀÕÕï¶ÏÒÇ£¬Ì½Í·ÆµÂÊ5MHZ¼°10MHZ¡£¼ì²éÒªÁ죺»¼ÕßÈ¡ºÏÊÊÌåλÓÚ¼ì²é´²ÉÏ£¬Ì½Í·Í¿ñîºÏ¼ÁºóÖÃÓÚÔöÉúÐÔñ£ºÛµÄÍâò¾ÙÐÐÊӲ졣B³¬²â¶¨±ê×¼£ºÓ¦ÓÃ×ðÁú¿­Ê±°ÌºÛÈí¸àÖÎÁÆÇ°£¬Ó¦ÓÃB³¬²â¶¨ÔöÉúÐÔñ£ºÛºñ¶È¼°ÊÓ²ìÔöÉúÐÔñ£ºÛÓëÖÜΧ×éÖ¯µÄÕ³Á¬¹ØÏµ£¬Ó¦ÓÃÊÓÆµÓ¡Ïó»ú¼Í¼²â¶¨Í¼Ïñ£¬ÒÔºóÿÖÎÁÆ1¸öÔ£¬ÕÉÁ¿Ò»´Î²¢¼Í¼£¬¾ÙÐÐǰºó±ÈÕÕ¡£
¡¡¡¡×ðÁú¿­Ê±°ÌºÛÈí¸àÓ¦ÓÃÒªÁ죺´´ÃæÓúºÏºó£¬ÏÈÓÃÇåˮϴåªÓúºÏºóƤ·ô£¬½«°ÌºÛÈí¸àÔȳÆÍ¿ÓÚÔöÉúÐÔñ£ºÛÉÏ£¬ÓÃÁ¿ÀàËÆÓÚÆäËûÈó·ôÆ·£¬²¢ÓÃÊÖÖ¸ÍÆÄÃ5·ÖÖÓ~10·ÖÖÓ£¨ÍÆÄÃÁ¦¶ÈÓ¦ÏàÒË£¬ÒÔ²»Ä¥ÆðË®ðåΪ¶È£©ÒÔÔöÌíÒ©ÎïµÄÎüÊÕ£¬È»ºóÅäºÏѹÁ¦ÁÆ·¨¡£ËùÓÐÖÎÁÆ»¼Õß¶¼¸øÓè×ÌÈÅËØ300ÍòIU£¨»ò500ÍòIU£©imqod»ò2´Î/ÖÜ£¬Æä×÷ÓûúÖÆÊÇÒÖÖÆ³ÉÏËάϸ°ûÔöÖ³£¬ÒÖÖÆ½ºÔ­ºÏ³ÉËùÐèµÄ¸¬°±ËáôÇ»¯Ã¸£¬×èÖ¹½ºÔ­±¬·¢£¬½µ½â½ºÔ­¡£×ðÁú¿­Ê±°ÌºÛÈí¸àÖðÈÕÓ¦ÓÃ3~4´Î£¬ÁƳÌ×î¶Ì6¸öÔ£¬×20¸öÔ¡£
1.4.Ч¹û£ºÖÎÁÆÏÔЧ120Àý£¬ÓÐÓÃ20Àý£¬ÎÞЧ0Àý£¬×ÜÓÐÓÃÂÊ100%¡£´¿´âÓ¦ÓÃѹÁ¦ÁÆ·¨µÄ»¼Õß»òÓ¦ÓÃѹÁ¦ÁÆ·¨+×ÌÈÅËØÖÎÁƵϼÕߣ¬ÏÔЧºÍÓÐÓÃʱ¼äÒª±ÈÓ¦ÓÃ×ðÁú¿­Ê±°ÌºÛÈí¸à+ѹÁ¦ÁÆ·¨+×ÌÈÅËØÖÎÁƵϼÕßÍí3¸öÔÂ×óÓÒ¡£±¾×鲡Àýδ·ºÆðƤ·ô¹ýÃô·´Ó¦£¬³ä·ÖÌåÏÖÁË×ðÁú¿­Ê±°ÌºÛÈí¸à×ÔÈ»ÖÐÒ©ÒòËØµÄÓÅÔ½ÐÔºÍÓÅÒìµÄƤ·ô˳ӦÐÔ¡£

2.ÌÖÂÛ
¡¡¡¡ñ£ºÛµÄÖÎÁÆÊÇÒ»¸öÖØ´óºã¾ÃµÄÀú³Ì£¬Ò²ÊÇ´´ÉË¿µ¸´ÊÂÇéÖеÄÒ»ÏîÖ÷ҪʹÃü£¬¸ÃÏîʹÃüµÄÖØµãÊÇÊÓ²ìÉÕÉË´´ÃæÓúºÏºóµÄ¼ÌÐøÖÎÁÆ£¬ÊÇ·ñÄÜÓÐÓÿØÖÆÔöÉúÐÔñ£ºÛºÍ×î´óÏ޶ȵرÜÃâ»ûÐα¬·¢£¬Í¬Ê±Ò²ÐèÒª»¼Õß¡¢¾ìÊô¼°¿µ¸´Ò½ÉúµÈ¶à·½ÃæµÄÅäºÏ¡£ñ£ºÛµÄÖÎÁƿɷÖΪ·ÇÊÖÊõÖÎÁƺÍÊÖÊõÖÎÁÆ¡£ÏÖÔÚ·ÇÊÖÊõÖÎÁÆÒªÁìËäÈ»Ðí¶à£¬µ«ÈÔÈ»²»¿ÉÓÐÓõؿØÖƲ¿·Ö»¼Õßñ£ºÛµÄÔöÉúºÍÂÎËõ£¬ÌØÊâÊÇÉÕÉËÃæ»ý½Ï´ó¡¢½ÏÉîµÄ»¼Õߣ¬ÖÎÁÆÆäÔöÉúÐÔñ£ºÛÓÐÒ»¶¨µÄÄѶȣ¬¹ÊÔöÉúºÍÂÎËõËùµ¼ÖµÄÓ°ÏìÃÀÈݺÍÊàŦ¹¦Ð§Õϰ­µÄ¸öÌ岡Àý£¬ÈÔÐèÊÖÊõÕû¸´¡£ÊÖÊõÕû¸´µÄÊõʽÓÐÐí¶à£¬µ«Êõǰ¶Ôñ£ºÛµÄºñ¶ÈºÍñ£ºÛ×éÖ¯±£´æµÄÌõÀíÆÊÎöÒÔ¼°ÓëÖÜΧ×éÖ¯µÄÕ³Á¬Ë®Æ½£¬ÁÙ´²ÉÐÎÞÈ·ÇеÄÏàʶҪÁì¡£×÷Õß¶àÄêÀ´ÖÂÁ¦ÓÚñ£ºÛµÄÁÙ´²Ñо¿£¬Ï뷨׷ÇóÒ»ÖÖÄÜÔÚÊÖÊõǰ׼ȷ·´Ó¦³öñ£ºÛ×éÖ¯±£´æµÄºñ¶ÈÒÔ¼°ÓëÖÜΧ×éÖ¯£¬ÌØÊâÊÇÓëÉ×éÖ¯µÄÆÊ½â¹ØÏµ¼°Õ³Á¬Ë®Æ½£¬ÆÚÍûΪÁÙ´²Ò½Ê¦ÌṩÀíÂÛ¼°ÐÎ̬ѧÒÀ¾Ý£¬Ìá¸ßÕûÐÎÊÖÊõÁÙ´²Ð§¹û¡£B³¬¼ì²éÒªÁì¾­¼Ã¡¢×¼È·¡¢Àû±ã¡¢ÎÞÍ´¿à£¬Ò×±»»¼Õß½ÓÊÜ£¬ÇÒÄÜÖ±½ÓÏÔʾÈí×éÖ¯¡¢¼¡½¡ºÍ¹Ç÷ÀµÄͼÏñ£¬Äܹ»Öظ´¼ì²é£¬ÆäÕï¶Ï׼ȷÂʽϸߣ¬²¢¿ÉÌṩ½ÏΪ¿É¿¿µÄͼÏñµÈÐÎ̬ѧ×ÊÁÏ£»µ«ñ£ºÛÍâòµÄ¸ßµÍ²»Æ½£¬¿ÉÓ°ÏìÕý³£µÄ¼ì²â£¬Ö»¹ÜÎÒÃǽÓÄÉÁËÒ»¶¨µÄµ÷½â²½·¥£¬µ«ÓÐʱ»¹»áÓ°Ïì²âÊÔЧ¹û£¬Óдý½øÒ»²½Ñо¿Ë¢Ð¡£
¡¡¡¡¹ØÓÚÁÆÐ§Åжϱê×¼£¬Leung£Û2£ÝÊÇÒÔÔöÉúÐÔñ£ºÛµÄÑÕÉ«£¬µ¯ÐÔ×ӵأ¬ºñ¶ÈµÈÖ¸±ê·ÖΪÈô¸ÉÆ·¼¶¡£ÑÕÉ«·ÖΪÉԺ죬·Ûºì£¬ºì£¬×Ϻ죬Éî×Ϻ죻µ¯ÐÔ·ÖΪºÜÈí£¬Èí£¬ÉÔÓ²£¬Ó²£¬¼áÓ²£»ºñ¶È·ÖΪºÜ±¡£¬±¡£¬ÉÔ±¡£¬ºñ£¬ÏÔ×ÅÔöºñ£¬½«ÒÔÉÏÈýÏîÖ¸±êµÄ¸÷¼¶×ۺϣ¬ÒÔ»®·ÖÔöÉúÐÔñ£ºÛµÄÑÏÖØË®Æ½£¬ÆäÖи÷ÏîÖ¸±êµÄÅжÏÖ÷ÒªÒÀÀµÈâÑÛÊӲ켰±ÈÕÕÏ໥½ÏÁ¿£¬µ¯ÐÔ¿ÉÓõ¯ÐԼƲⶨ¡£±ê×¼½ÓÄɵÄÊǺ£ÄÚÌÆÏþìäÌá³öµÄ±ê×¼£Û3£Ý£¬ÒÔΪÕâÖÖ±ê×¼½ÏÁ¿¹æ·¶£¬±ãÓÚÁÙ´²Ê¹Óá£
¡¡¡¡½«ÊÖÊõÓë·ÇÊÖÊõÁÆ·¨ÍŽáÔÚÒ»ÆðÓ¦Ó㬼´×ÛºÏÖÎÁÆ£¬ÊÇñ£ºÛÖÎÁƵij£ÓÃÒªÁìºÍ×ܵÄÖ¸µ¼Í·ÄÔ¡£µ«Ñ°ÕÒÒ»¸ö¾­¼ÃÓÐÓõÄ×ÛºÏÖÎÁƼƻ®ÎÞÒì¶Ô»¼ÕßÊÇÏàÒ˵Ä¡£¼ÓѹÁÆ·¨£º´´ÃæÓúºÏºó£¬ÊµÊ±½ÓÄɵ¯Á¦±Á´ø£¬µ¯Á¦ÍøÌ×µÈÓþ߼Óѹ°üÔú£¬²¢Ó¦Óüаå¼á³ÖÊàŦÓÚ¹¦Ð§Î»£¬¿ÉÓÐÓõØïÔÌ­ñ£ºÛÔöÉúÓëñ£ºÛÂÎËõ£¬´Ë·¨µÄÁÆÐ§ÊÇÈ·¶¨µÄ¡£µ«Ñ¹Á¦ÁÆ·¨Ò²ÓÐÒ»¶¨µÄ¾ÖÏÞÐÔ£¬Ò»Ð©²¿Î»ÊÇÎÞ·¨Ê©ÐеÄ¡£ÉúÎï»îÐÔÀàÒ©ÎïÈç×ÌÈÅËØµÄÓ¦Óãº×ÌÈÅËØÊÇÒ»ÖÖÆÕ±éÓÃÓÚ¿¹ÏËά»¯¼²²¡µÄÒ©ÎÓÐIFN-a¡¢IFN-¦Â¡¢IFN-r 3ÖÖÀàÐÍ£¬×÷ÓûúÖÆÊÇÒÖÖÆ³ÉÏËάϸ°ûÔöÖ³£¬ÒÖÖÆ½ºÔ­ºÏ³ÉËùÐèµÄ¸¬°±ËáôÇ»¯Ã¸£¬×èÖ¹½ºÔ­±¬·¢£¬½µ½â½ºÔ­£¬Ó¦ÓÃ×ÌÈÅËØÖÎÁÆñ£ºÛÔöÉúÊÇÓ¦ÓÃѹÁ¦ÁÆ·¨µÄÓÅÒìÔö²¹£¬ÓÈÆä¹ØÓڽϴóÃæ»ýÉÕÉË»¼ÕßµÄñ£ºÛÔöÉú·ÀÖÎÓÐÒ»¶¨µÄÓÅÔ½ÐÔ¡£×ðÁú¿­Ê±°ÌºÛÈí¸àÈí¸àÌáÈ¡´¿×ÔȻֲÎïÒòËØ£¬Æä»îÐÔÒòËØÄÜÒÖÖÆÏËάϸ°ûÔöÉú£¬»Ö¸´Æ¤·ôÕý³£×éÖ¯½á¹¹ºÍÐÄÀí¹¦Ð§£¬Ôö½øÆ¤Ö¬ÏÙÔÙÉú£¬»Ö¸´¾Ö²¿ÐÄÀíÇéÐΣ¬µÖ´ïÈí»¯Æ½¸´ñ£ºÛµÄÄ¿µÄ¡£
¡¡¡¡B³¬¼ì²âÊÇÅжÏñ£ºÛÔöÉúÇéÐεÄÒ»ÖÖÓÅÒìµÄÁÙ´²¼ì²âÒªÁ죬ÄÜ׼ȷµØ·´Ó¦³öñ£ºÛµÄºñ¶È¼°ÓëÖÜΧµÄ±ÈÁÚ¹ØÏµ²¢×ö³ö¶¨Î»Õï¶Ï£¬Í¬Ê±»¹¿É¶àÆ½Ãæ£¬Öظ´Ó¦Óã¬ÎÞ¸¨ÉäÖ®Îó²î£¬Õâ¶ÔÁÙ´²ÉÏñ£ºÛµÄÖÎÁƼà²âÓÐÖ÷ÒªÖ¸µ¼ÒâÒå¡£ÎÒ¿ÆÓ¦ÓÃ×ðÁú¿­Ê±°ÌºÛÈí¸à+ѹÁ¦ÁÆ·¨+×ÌÈÅËØÍŽáÖÎÁÆ470Àýñ£ºÛ»¼Õߣ¬ÆäÖÐ140Àý»¼Õß½ÓÄÉÁËB³¬¸ú×ٲⶨ£¬È¡µÃÁËÖª×ãЧ¹û£¬Ó¦ÓÃÕâÖÖÖÎÁÆÒªÁ죬ÁÆÐ§¿É¿¿£¬»¼ÕßÒ×ÓÚ½ÓÊÜ£¬ÇÒ¾­¼ÃÊÊÓ㬱ãÓÚÁÙ´²ÆÕ±éÍÆ¹ã¡£

²Î¿¼ÎÄÏ×
[1]²Ì¾°Áú£¬ÕÅ×Úѧ.ÏÖ´úñ£ºÛÖÎÁÆÑ§£ÛM£Ý.±±¾©.ÈËÃñÎÀÉú³öÊéÉ磬1998.
[2]Leung KS£¬et al.Microcirculation in hypertrophic  scar after burn injury£¬JBurn Care Rehabil£¬1989£¬10£º436~444.
[3]ÌÆÏþì䣬ÑîÀöÓ¢£¬Ê·¼ÃÏæ£¬µÈ.µ¯Á¦Ì×ÖÎÁÆÉÕÉ˺óÔöÉúÐÔñ£ºÛ£ÛJ£Ý.ÖлªÕûÐÎÉÕÉËÍâ¿ÆÔÓÖ¾£¬1994£¬4£º267~269.

¡¾×÷Õß¼ò½é¡¿
ÁõÍò»Ô£¨1970~£©£¬ÄУ¨ºº×壩£¬ºÚÁú½­Ê¡¼Ñľ˹ÊÐÈË£¬½áÒµÓÚ¼Ñľ˹ҽѧԺÁÙ´²Ò½Ñ§Ïµ£¬¸±Ö÷ÈÎҽʦ£¬¿ÆÖ÷ÈÎ.
ÁõÉÆÎ䣨1972~£©£¬ÄУ¨ºº×壩£¬É½¶«Ê¡×Ͳ©ÊÐÈË£¬½áÒµÓÚɽ¶«ÖÐÒ½Ò©´óѧ£¬Ö÷ÖÎҽʦ.
Ëï¡¡±ò£¨1980~£©£¬ÄУ¨ºº×壩£¬É½¶«Ê¡×Ͳ©ÊÐÈË£¬½áÒµÓÚΫ·»Ò½Ñ§ÔºÁÙ´²Ò½Ñ§Ïµ£¬Ò½Ê¦.

£¨ÊÕ¸åÈÕÆÚ£º2009-07-13£©

ÍøÕ¾µØÍ¼